Apteki 36.6 Financial Statements (APTK)
|
|
|
|
Report date
|
|
|
08.08.2023 |
17.07.2023 |
02.05.2024 |
29.04.2025 |
17.02.2026 |
|
Currency
|
|
|
RUB |
RUB |
RUB |
RUB |
RUB |
|
Financial report URL
|
|
|
|
|
|
|
|
|
Annual report URL
|
|
|
|
|
|
|
|
|
Presentation URL
|
|
|
|
|
|
|
|
|
|
Number of stores, pcs. |
|
|
|
|
|
2 554 |
|
|
New stores opened, pcs. |
|
|
|
|
|
403 |
|
|
Like for like sales, % |
? |
|
|
|
|
|
7.9% |
|
Online Sales, bln rub |
|
|
|
|
|
|
30.0 |
|
|
Revenue, bln rub |
? |
|
44.1 |
59.1 |
67.4 |
87.2 |
117.4 |
|
Operating Income, bln rub |
|
|
|
|
4.27 |
6.76 |
|
|
EBITDA, bln rub |
? |
|
|
|
5.89 |
8.55 |
8.50 |
|
Net profit, bln rub |
? |
|
-0.950 |
0.223 |
0.921 |
0.866 |
|
|
Net profit not adj., bln rub |
? |
|
|
|
0.120 |
0.267 |
|
|
|
OCF, bln rub |
? |
|
3.23 |
6.60 |
7.05 |
6.49 |
|
|
CAPEX, bln rub |
? |
|
0.980 |
0.980 |
1.28 |
1.51 |
|
|
FCF, bln rub |
? |
|
-1.71 |
1.64 |
1.93 |
0.450 |
|
|
|
Ordinary share dividend yield, %
|
|
|
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
|
Dividend payout ratio, %
|
|
|
0% |
0% |
0% |
0% |
|
|
|
OPEX, bln rub |
|
|
|
|
18.1 |
22.0 |
|
|
Cost of production, bln rub |
|
|
29.0 |
38.9 |
45.1 |
58.7 |
|
|
Amortization, bln rub |
|
|
5.8 |
5.8 |
6.0 |
6.6 |
|
|
Employment expenses, bln rub |
|
|
6.78 |
7.92 |
8.91 |
11.6 |
|
|
Interest expenses, bln rub |
|
|
4.92 |
4.27 |
2.44 |
4.27 |
|
|
|
Assets, bln rub |
|
|
37.8 |
43.6 |
53.2 |
60.8 |
|
|
Net Assets, bln rub |
? |
|
-6.65 |
-6.41 |
-6.83 |
-7.56 |
|
|
Debt, bln rub |
|
|
21.6 |
18.9 |
20.7 |
23.1 |
|
|
Cash, bln rub |
|
|
1.73 |
0.810 |
2.09 |
1.96 |
|
|
Net debt, bln rub |
|
|
19.9 |
18.1 |
18.6 |
21.2 |
0.00 |
|
|
Ordinary share price, rub |
|
|
14.0 |
11.6 |
14.2 |
11.5 |
8.49 |
|
Number of ordinary shares, mln |
|
|
2 331 |
2 331 |
7 630 |
7 630 |
7 630 |
|
|
Market cap, bln rub |
|
|
32.5 |
27.0 |
108.5 |
87.7 |
64.8 |
|
EV, bln rub |
? |
|
52.4 |
45.1 |
127.1 |
108.9 |
64.8 |
|
Book value, bln rub |
|
|
-19.5 |
-19.9 |
-24.0 |
-27.2 |
0.00 |
|
|
EPS, rub |
? |
|
-0.41 |
0.10 |
0.12 |
0.11 |
0.00 |
|
FCF/share, rub |
|
|
-0.73 |
0.70 |
0.25 |
0.06 |
0.00 |
|
BV/share, rub |
|
|
-8.37 |
-8.54 |
-3.15 |
-3.56 |
0.00 |
|
|
EBITDA margin, % |
? |
|
0.0% |
0.0% |
8.7% |
9.8% |
7.2% |
|
Net margin, % |
? |
|
-2.2% |
0.4% |
1.4% |
1.0% |
0.0% |
|
FCF yield, % |
? |
|
-5.3% |
6.1% |
1.8% |
0.5% |
0.0% |
|
ROE, % |
? |
|
14.3% |
-3.5% |
-13.5% |
-11.5% |
|
|
ROA, % |
? |
|
-2.5% |
0.5% |
1.7% |
1.4% |
|
|
|
P/E |
? |
|
-34.2 |
120.9 |
117.8 |
101.3 |
|
|
P/FCF |
|
|
-19.0 |
16.4 |
56.2 |
195.0 |
|
|
P/S |
? |
|
0.74 |
0.46 |
1.61 |
1.01 |
0.55 |
|
P/BV |
? |
|
-1.67 |
-1.35 |
-4.52 |
-3.23 |
|
|
EV/EBITDA |
? |
|
|
|
21.6 |
12.7 |
7.62 |
|
Debt/EBITDA |
|
|
|
|
3.16 |
2.47 |
0.00 |
|
|
R&D/CAPEX, % |
|
|
0.00% |
0.00% |
0.00% |
0.00% |
|
|
|
CAPEX/Revenue, % |
|
|
2% |
2% |
2% |
2% |
0% |
|
| Apteki 36.6 shareholders |
